Investigation of the performance of serological assays used for Lyme disease testing in Australia.
Spirochaetes of the Borrelia burgdorferi sensu lato complex, which includes those that cause Lyme disease, have not been identified in Australia. Nevertheless, Australian patients exist, some of whom have not left the country, who have symptoms consistent with so-called "chronic Lyme disease&qu...
Main Authors: | Susan J Best, Marlene I Tschaepe, Kim M Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0214402 |
Similar Items
-
Improved Serodiagnostic Testing for Lyme Disease: Results of a Multicenter Serologic Evaluation
by: Robert B. Craven, et al.
Published: (1996-04-01) -
?Lyme Disease in Australia-Still To Be Proven!
by: Richard C. Russell
Published: (1995-01-01) -
Serological evidence of possible Borrelia afzelii lyme disease in Greece
by: I. Karageorgou, et al.
Published: (2022-03-01) -
Canine Serology as Adjunct to Human Lyme Disease Surveillance
by: Paul S. Mead, et al.
Published: (2011-09-01) -
Recombinant Antigens In Serological Diagnosis Of Lyme Borreliosis
by: Grąźlewska Weronika, et al.
Published: (2019-01-01)